Abstract

Overall response to consent (Yes%/No%/Unknown %): 99% Yes Total individual cases held: 800 % cases associated with fresh-frozen tumor biospecimens: 25% % cases with paraffin embedded biospecimens: 97% % cases with blood and blood derivatives: 80%
1) Cases with a full set of biospecimens i.e., frozen tissue, FFPE tissue and blood. 2) Cases with fully detailed clinical and treatment data. 3) Cases with the longest period of follow-up.
1) Completing the collection of informed consent from donors in the midst of intense clinical activity. 2) Collecting follow-up information over a long period. 3) Balancing the competing demands of investigators who want to access specimens for immediate use, and retaining samples until long term follow-up data is available.
Invest in centralized high-throughput processing and basic analysis of biospecimens.
